Scholarlink

Background <p>Adenoid ameloblastoma (AA) is a newly recognized, rare odontogenic tumor variant, distinguished by histopathological features that combine characteristics of both ameloblastoma and adenomatoid odontogenic tumor. </p> Case report <p>A 32-year-old female with an unilocular radiolucent lesion in the mandible associated with the impacted third molar, diagnosed as AA. Surgical management included complete lesion excision and cryotherapy. Despite the absence of significant symptoms, clinical surveillance is essential, as AA may have high recurrence rates. The recent inclusion of this entity in the WHO Head and Neck Tumor Classification (2022) highlights the need for accurate diagnosis and appropriate interventions to optimize patient prognosis. </p> Conclusion <p>This report not only contributes to the growing understanding of this tumor biological behavior but also highlights the clinical relevance of documenting such cases to guide best practices and improve prognostic insights in rare odontogenic lesions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adenoid ameloblastoma: Conservative approach in a rare odontogenic lesion

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月23日

查看全文
  • Eduardo dos Santos Vidal,
  • William Cezar da Silveira,
  • Camila Cerantula Moura,
  • Hélen Kaline Farias Bezerra,
  • Pablo Agustin Vargas,
  • Juliana Lucena Schussel,
  • Leandro Eduardo Klüppel,
  • Heliton Gustavo de Lima

摘要

Background

Adenoid ameloblastoma (AA) is a newly recognized, rare odontogenic tumor variant, distinguished by histopathological features that combine characteristics of both ameloblastoma and adenomatoid odontogenic tumor.

Case report

A 32-year-old female with an unilocular radiolucent lesion in the mandible associated with the impacted third molar, diagnosed as AA. Surgical management included complete lesion excision and cryotherapy. Despite the absence of significant symptoms, clinical surveillance is essential, as AA may have high recurrence rates. The recent inclusion of this entity in the WHO Head and Neck Tumor Classification (2022) highlights the need for accurate diagnosis and appropriate interventions to optimize patient prognosis.

Conclusion

This report not only contributes to the growing understanding of this tumor biological behavior but also highlights the clinical relevance of documenting such cases to guide best practices and improve prognostic insights in rare odontogenic lesions.